ArticleCancers2021

Combined Assessment of Immune Checkpoint Regulator VISTA on Tumor-Associated Immune Cells and Platelet-to-Lymphocyte Ratio Identifies Advanced Germ Cell Tumors with Higher Risk of Unfavorable Outcomes.

Rafał Pęksa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.